2.69
price down icon3.58%   -0.10
after-market Handel nachbörslich: 2.79 0.10 +3.72%
loading

Finanzdaten der Inozyme Pharma Inc-Aktie (INZY)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
6.74%
24.34
22.81 18.07 16.39 18.37
Interest Income/Expense
1.325
- - - -
Depreciation and Amortization
3.41%
0.182
0.176 0.208 0.209 0.207
Operating Income/Loss
6.74%
-24.34
-22.81 -18.07 -16.39 -18.37
Nonoperating Income/Loss
21.04%
0.998
1.264 1.436 0.811 0.965
Income/Loss From Continuing Operations Before Tax
8.37%
-23.35
-21.54 -16.64 -15.58 -17.40
Income/Loss From Continuing Operations After Tax
8.37%
-23.35
-21.54 -16.64 -15.58 -17.40
Net Income/Loss
8.37%
-23.35
-21.54 -16.64 -15.58 -17.40
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,747%
61.77
3.345 56.76 44.86 43.72
Diluted Average Shares
1,747%
61.77
3.345 56.76 44.86 43.72
Basic Earnings Per Share
8.57%
-0.38
-0.35 -0.29 -0.35 -0.40
Diluted Earnings Per Share
8.57%
-0.38
-0.35 -0.29 -0.35 -0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):